These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7028183)

  • 1. Exploitation of monoclonal antibodies: a "who's who" of haemopoietic malignancy.
    Greaves MF; Delia D; Robinson J; Sutherland R; Newman R
    Blood Cells; 1981; 7(2):257-80. PubMed ID: 7028183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface markers in leukemia: biological and clinical correlations.
    Thiel E
    Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic diversity of T cell leukemias.
    Greaves MF
    J Clin Immunol; 1982 Jul; 2(3 Suppl):75S-80S. PubMed ID: 6982279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional characterization of human malignant T cells.
    Harden EA; Haynes BF
    Semin Hematol; 1985 Jan; 22(1):13-26. PubMed ID: 3918348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation.
    Boumsell L; Bernard A; Coppin H; Richard Y; Penit C; Rouget P; Lemerle J; Dausset J
    J Immunol; 1979 Nov; 123(5):2063-7. PubMed ID: 90700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.
    Greaves MF; Janossy G; Peto J; Kay H
    Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of HLA-DR antigens on leukaemic cells.
    Newman RA; Greaves MF
    Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunodiagnosis of chronic lymphatic leukemia and leukemic non-Hodgkin's lymphoma with the monoclonal antibodies BL-Ig-L/1, BL-DR/1 and BL-T2].
    Malberg K; Fischer H; Elendt D; Wutke K; Fiebig H
    Arch Geschwulstforsch; 1984; 54(4):325-32. PubMed ID: 6437368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double fluorochrome analysis of human bone marrow lymphoid cells: studies with terminal transferase and anti-T-cell monoclonal antibodies.
    Neudorf SM; Le Bien TW; Bollum F; Kersey JH
    Exp Hematol; 1984 Jan; 12(1):69-73. PubMed ID: 6607843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
    LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
    J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological classification of acute lymphoblastic leukemias (ALL) in childhood. Origin and clinical significance of phenotypic variability].
    Thöne I; Kabisch H; Müller J; Winkler K; Landbeck G
    Monatsschr Kinderheilkd; 1982 Dec; 130(12):883-90. PubMed ID: 6759928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype.
    Babusíková O; Tomová A
    Neoplasma; 2002; 49(5):312-8. PubMed ID: 12458329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies.
    Bradstock KF; Janossy G; Pizzolo G; Hoffbrand AV; McMichael A; Pilch JR; Milstein C; Beverley P; Bollum FJ
    J Natl Cancer Inst; 1980 Jul; 65(1):33-42. PubMed ID: 6993744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in clonal expression during the course of acute leukemia: possible subsets in childhood leukemia.
    Hann HW; Nowell PC; Koch P; Minowada J; Leitmeyer JE; August CS
    J Natl Cancer Inst; 1982 Aug; 69(2):393-9. PubMed ID: 7050498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J
    Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.